Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$39.42 - $48.08 $543,996 - $663,504
-13,800 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$32.49 - $45.96 $448,362 - $634,248
13,800 New
13,800 $563,000
Q3 2019

Nov 01, 2019

SELL
$40.05 - $57.47 $240,299 - $344,820
-6,000 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$30.3 - $41.14 $80,719 - $109,596
-2,664 Reduced 30.75%
6,000 $244,000
Q1 2019

May 02, 2019

SELL
$29.37 - $40.49 $97,978 - $135,074
-3,336 Reduced 27.8%
8,664 $262,000
Q2 2018

Aug 10, 2018

BUY
$28.77 - $48.27 $172,620 - $289,620
6,000 Added 100.0%
12,000 $384,000
Q1 2018

May 09, 2018

SELL
$49.22 - $68.43 $49,220 - $68,430
-1,000 Reduced 14.29%
6,000 $298,000
Q3 2017

Nov 01, 2017

BUY
$51.16 - $58.21 $358,120 - $407,470
7,000
7,000 $406,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $260M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.